Omeros files infringement suits against Par Pharmaceutical
Omeros Corp. announced it has filed patent infringement lawsuits against Par Pharmaceutical. The lawsuits were filed under the Hatch-Waxman Act for Par's infringement of three Omeros patents which relate to Omeros' drug Omidria® (phenylephrine and ketorolac injection) 1%/0.3%. September 03, 2015